Second Sight Medical Products Inc (EYES)

[zitry]

Pat Ryan joining EYES shows Second Sight Medical can attract great high caliber executives. Take a look at Insulet (PODD) where he served as COO. PODD is a very impressive high flyer. Hints are given in the press release of very positive news to come from ORION not relating to to current sales but I believe a technological breakthrough is on the cusp. The main reason EYES hired Pat Ryan is to start gearing up manufacturing to meet the future high demand for ORION. The market for ORION is well defined and huge. EYES is by far the world leader. EYES clearly believes they must now build the infrastructure to meet the manufacturing demands which will come quickly once ORION proves beyond a shadow of a doubt that useful vision can be restored in virtually all cases of blindness. I am confident they will as it has already been reported all 60 electrodes are functioning in current patients. Now the algorithm scientist and the software developers need to figure out how to interpret the data. Look at the following passage and read between the lines. This appears to be a precursor for what is to come.

EYES is extremely careful right now not to spill the beans as insiders continue to gobble up EYES stock. Couple this with the hiring of Jack Ryan and the pieces come together in startling clarity. EYES continues to be screaming buy! Do not expect this quarter's financial results will be anything but lackluster. For me this is irrelevant right now! EYES stock will be priced based on on the clearly defined market and the market-share EYES can achieve. My research indicates their market-share could easily be 70% to 90%. EYES has competitors and the best competitor is a distant second. Here is the passage in the press release that tells much of the story. Read between the lines.

"- - - Second Sight continues to develop the Orion™ Cortical Visual Prosthesis System (Orion) and prepares for significantly higher manufacturing volumes in future years,” said McGuire.

“Pat has the perfect background to ready Second Sight for an exciting future with Orion. His strong leadership in key areas will be invaluable, as we move the Orion clinical and development programs forward and prepare for success in a market that includes hundreds of thousands of potential patients worldwide,” said Gregg Williams, Chairman of the Board.- - - "